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Abstract.  We have explored the composition and sta- 
bility properties of individual microtubules (MTs) in 
the axons of cultured sympathetic neurons.  Using mor- 
phometric means to quantify the MT mass remaining 
in axons after various times in 2  #g/ml nocodazole, 
we observed that ~48%  of the MT mass in the axon 
is labile, depolymerizing with a  t1/2 of "-,5 min, 
whereas the remaining 52%  of the MT mass is stable, 
depolymerizing with a  tt/2 of r~ 240 min. Im- 
munofluorescence analyses show that the labile MTs in 
the axon are rich in tyrosinated ot-tubulin, whereas the 
stable MTs contain little or no tyrosinated ot-tubulin 
and are instead rich in posttranslationally detyrosi- 
nated and acetylated o~-tubulin.  These results were 
confirmed quantitatively by immunoelectron micro- 
scopic analyses of the distribution of tyrosinated 
ot-tubulin among axonal MTs. Individual MT profiles 
were typically either uniformly labeled for tyrosinated 
ot-tubulin all along their length, or were completely 
unlabeled. Roughly 48%  of the MT mass was tyrosi- 
nated,  ~52%  was detyrosinated, and ~85%  of the 
tyrosinated MTs were depleted within 15 min of 
nocodazole treatment. Thus, the proportion of MT 
profiles that were either tyrosinated or detyrosinated 
corresponded precisely with the proportion of MTs 
that were either labile or stable respectively. We also 
observed. MT profiles that were densely labeled for 
tyrosinated a-tubulin at one end but completely unla- 
beled at the other end. In all of these latter cases, the 
tyrosinated, and therefore labile domain, was situated 
at the plus end of the MT,  whereas the detyrosinated, 
and therefore stable domain was situated at the minus 
end of the MT, and in each case there was an abrupt 
transition between the two domains. Based on the fre- 
quency with which these latter MT profiles were ob- 
served, we estimate that minimally 40%  of the MTs in 
the axon are composite, consisting of a  stable 
detyrosinated domain in direct continuity with a  labile 
tyrosinated domain. The extreme drug sensitivity of 
the labile domains suggests that they are very dy- 
namic, turning over rapidly within the axon. The di- 
rect continuity between the labile and stable domains 
indicates that labile MTs assemble directly from stable 
MTs.  We propose that stable MTs act as MT nucleat- 
ing structures that spatially regulate MT dynamics in 
the axon. 
M 
ICROTUBULES (MTs) ~ are actively involved in the 
growth and maintenanceof  the axon. This was ini- 
tially inferred from ultrastructural studies of MT 
organization in growing axons (Yamada et al.,  1971; Peters 
et al., 1974)~ and from pharmacologic studies demonstrating 
that anti-MT drugs inhibit the growth of axons and can cause 
their retraction (Yamada et al., 1970;  Daniels, 1973).  Since 
these initial observations were made, considerable effort has 
been devoted toward defining in molecular terms the mecha- 
nisms by which MT assembly and organization are regulated 
in the axon (for reviews, see Lasek, 1988; Meininger and Bi- 
net,  1989;  Diaz-Nido et al.,  1990). 
To date, most information on MT assembly and organiza- 
tion derives from in vitro studies on isolated MT proteins, 
or from studies on nonneuronal cells. These studies have es- 
tablished that MTs are assembled from tubulin subunits, and 
are intrinsically polar in their assembly kinetics (for review, 
1. Abbreviation  used in this paper:  MT, microtubule. 
see Dustin, 1984). One end of the MT is favored for assembly 
over the other (for review, see Binder et al., 1975), and these 
two ends of the MT are referred to as the "plus" and "minus" 
end respectively (Bergen and Borisy,  1980). In the test tube, 
MT assembly can occur de novo by self-association of free 
sub/mits, but preferentially occurs by elongation from a MT 
template or nucleating structure (for review, see Kirschner, 
1978).  Studies on MT assembly in intact cells indicate that 
self-association is strongly suppressed in favor of nucleated 
assembly, and that MT nucleation is spatially regulated by 
discrete nucleating structures such as the centrosome (for re- 
view, see Brinkley, 1985).  The minus ends of the MTs are 
directly associated with the nucleating structure, while the 
plus ends radiate away from the nucleating structure (Haimo 
et al.,  1979;  Heidemann and Mclntosh,  1980;  Euteneuer 
and  McIntosh,  1981). Thus,  a  hallmark  feature  of MT 
nucleating structures is that they generate MT arrays of uni- 
form polarity orientation. 
It is now well established that MTs in the axon also have 
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directed  away  from  the  cell  body  toward  the  axon  tip 
(Heidemann et al.,  1981; Burton and Paige,  1981; Baas et 
al.,  1987, 1988, 1989).  Because axonal MTs are dynamic 
polymers,  undergoing  assembly  and  disassembly  locally 
within  the  axon  (Morris  and  Lasek,  1984;  Okabe  and 
Hirokawa, 1988; Black et al., 1989), mechanisms must exist 
within the axon to organize local MT dynamics so that uni- 
form polarity orientation is maintained. This conclusion is 
reinforced by the observation that the uniform polarity orien- 
tation of  axonal MTs is recapitulated after recovery from epi- 
sodes of MT depolymerization (Heidemann et al.,  1984; 
Baas et al., 1987). Thus, it is likely that nucleating structures 
organize MT dynamics locally in the axon. However, axons 
lack traditional MT nucleating structures such as the centro- 
some (Lyser, 1968; Sharp et al., 1982; Stevens et al., 1988; 
Okabe and Hirokawa, 1988), and there is no structural evi- 
dence of specializations at the minus ends of axonal MTs 
which  could  serve  as  nucleating  structures  (Chalfie and 
Thompson,  1979;  Bray  and  Bunge,  1981; Tsukita  and 
Ishikawa, 1981). What are the structures that serve as tem- 
plates for local MT dynamics in the axon? 
It has been hypothesized by several  authors that a unique 
class of especially stable MTs may act as the nucleating struc- 
tures for MT dynamics in the axon (Brady et al.,  1984; 
Morris and Lasek, 1984; Black et al.,  1984; Heidemann et 
al., 1984; Baas and Heidemann, 1986). A key prediction of 
this model is that individual MTs in the axon will consist of 
a stable domain in direct continuity with a newly assembled 
domain. The newly assembled domain is presumably more 
labile than the stable domain in that MT stabilization is 
thought to occur only after a temporal delay after MT assem- 
bly (Kirschner and Mitchison, 1986; Khawaja et al., 1988). 
In support of the view that axonal MTs consist of stable and 
labile domains, stable and labile MTs have been identified 
in the axon (Brady et al.,  1984;  Morris and Lasek, 1982, 
1984; Black et al., 1984,  1989), and it has been shown that 
the MTs remaining in the axon after episodes of MT depoly- 
merization are generally shorter than the MTs present in the 
unperturbed axon (Baas and Heidemann, 1986; Joshi et al., 
1986;  Sahenk and Brady, 1987).  However,  to date, no evi- 
dence has been provided which directly demonstrates con- 
tinuity between stable and labile MTs in the axon. 
Here,  we document a  compositional difference between 
stable and labile MTs in the axon that permits us for the first 
time to simultaneously visualize and distinguish them at the 
electron microscopic  level,  and hence directly determine 
their spatial relationship relative to one another. In many 
types of MT arrays, posttranslational detyrosination occurs 
on a portion of the ot-tubulin after its incorporation into MTs 
(Gunderson et al., 1987), such that the more recently assem- 
bled, labile MTs are rich in the tyrosinated form of a-tubulin, 
whereas the older, more stable MTs are rich in the detyrosi- 
hated form (Gunderson and Bulinski, 1986;  Schulze et al., 
1987; Kreis, 1987; Webster et al., 1987; Wheland and Web- 
er, 1987; Gunderson et al., 1987; Bulinski et al., 1988). Our 
data indicate that this is also the case in the axon. Labile MTs 
label with the mAb YL 1/2, which recognizes the tyrosinated 
but not the detyrosinated form of tx-tubulin (Kilmartin et al., 
1982; Wheland et al., 1983), whereas stable MTs do not la- 
bel with this antibody. Using YL 1/2 in immunoelectron mi- 
croscopic  analyses,  we demonstrate direct continuity be- 
tween stable and labile MTs in the axon. Thus, individual 
MTs in the axon consist of distinct stable and labile domains. 
Materials and Methods 
Cell Culture 
Rat sympathetic neurons were grown either as dissociated cultures or as ex- 
plant cultures. For dissociated cultures, superior cervical ganglia were dis- 
sected from 1-5-d rat pups, treated with 0.25 mg/ml collagenase for 1 h fol- 
lowed by 0.25 mg/ml  trypsin for 45 rain, and then triturated with a Pasteur 
pipette into a  single cell dispersion. The neurons were then plated onto 
collagen-coated 35-ram tissue culture dishes in N2 medium (Moya et al., 
1980) supplemented with 2.5% FCS, 5% human placental serum, 50 ng/ml 
nerve growth factor, and 0.6% methyl cellulose. Cultures were fed the fol- 
lowing morning with the same medium without the methyl cellulose, but 
containing 5 t~M cytosine arabinoside to reduce nonneuronal contamina- 
tion. After 10-14 d in culture, the neurons were transplanted to glass cham- 
ber slides that had been coated with polyethylene  amine and collagen as pre- 
viously described (Black and geyser, 1987).  FOr transplantation, cultures 
were rinsed twice in PBS, and then treated with 0.25 mg/ml collagensse for 
15 min to release the neurons from the substratum. The floating mass of 
neurons, held together by a dense network of neurites, was then lifted from 
the culture dish, treated for 15 min with 0.25% trypsin and triturated into 
a single cell dispersion. Cell bodies were separated from remnants of the 
neurites by centrifugation, and were then plated into the chamber slides. 
For most experiments reported here, the transplanted neurons were main- 
tained for 7-10 d before experimentation, although comparable results were 
obtained with cultures ranging in age from 3-14 d. This procedure resulted 
in moderate to low density cultures in which individual neurons generated 
readily distinguishable axons and dendrites. 
Explant cultures were prepared using a procedure slightly modified from 
Peng et al.,  1986. Briefly,  sympathetic ganglia were cut into 2-3 pieces/ 
ganglion, and placed into collagen-coated 35-mm culture dishes containing 
N2 medium supplemented with 1% human placental serum, 50 ng/ml nerve 
growth factor, and 0.6%  methyl cellulose. Only 3-4 explants were grown 
per dish so that the axonal networks of neighboring  explants did not overlap. 
Cultures were fed the next morning with the same medium without the 
methyl cellulose and serum, but containing 10/~M cytosine arabinoside, 
and were maintained for 7-10 d before experimentation. Explant cultures 
were a great advantage for electron microscopic analyses of axonal MTs be- 
cause they consist of a centralized cell body mass that extends a dense halo 
of aligned axons, hundreds of which could be thin-sectioned simultaneously 
without contamination from cell bodies, dendrites, or nonneuronal cells 
(see Fig.  1). 
Effects of  Nocodazole on Axonal Microtubules 
To quantify the effects of nocodazole on axonal MTs, explant cultures were 
treated for times ranging between 0 and 360 min with 2 #g/mI nocodazole 
(Aldrich Chemical Co., Milwaukee, WI), and then prepared for electron 
microscopy as previously described (Baas and Heidemann,  1986).  After 
embedment in resin, regions of  the axonal halo were sectioned, viewed elec- 
tron microscopically, and photographed. Total lengths of MT profiles were 
measured in the electron micrographs for each time point, and standardized 
to unit area of axoplasm. The latter was determined by trimming all empty 
space from the electron micrographs and weighing the micrographs as pre- 
viously described (White et al., 1987).  The MT mass remaining after drug 
tw~tment was then expressed as a function of  the MT mass in control axons. 
Immunofluorescence  Analyses 
Cultures on chamber slides were prepared for immunofluoresconce  analyses 
using one of two extraction protocols, a harsher protocol for the moderate 
density cultures, and a milder protocol for the low density cultures. For the 
first, cultures were rinsed briefly in PHEM buffer (60 mM Pipes, 25 mM 
Hepes, 10 mM EGTA, 2 mM MgCl2 [pH 6.9]; Schliwa and van Blerkom, 
1981), and then extracted for 10 min with 1% Triton X-100 in PHEM also 
containing 10/~M taxol (gift from the National Cancer Institute) and 0.2 M 
NaC1 to remove free tubulin but stabilize existing MTs (Black et al., 1986). 
For the second, cultures were rinsed briefly in PHEM, and extracted for 
5 rain with 0.2% Triton X-100 in PHEM containing 10/~M taxol but no 
NaC1.  For most experiments, extracted cultures were fixed by immersion 
in -20°C methanol for 10 min, rinsed with PBS, and incubated for 15 min 
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halo. Insert (b) shows a typical region of pure axons used for electron microscopic analyses of axonal MTs. Bar,  100 tLm. 
in a blocking solution containing 2% normal goat serum and 1% BSA. Cul- 
tures were then incubated with two primary antibodies (see below) simul- 
taneously for 1 h at 35"C, rinsed extensively,  incubated again for 15 min 
in blocking solution, incubated with two appropriate fluorescently  tagged 
second antibodies simultaneously for 1 h at 35"C, and rinsed extensively 
gain. The slides were then removed  from their chambers, mounted with 
a coverslip, and viewed with a Zeiss Axiovert 35 microscope using epiflu- 
orescence optics.  In a limited number of experiments,  extracted cultures 
were fixed with 0.5 % glutaraldehyde in PHEM for 10 rain at room tempera- 
ture, rinsed with PBS, incubated with 2 mg/ml sodium borohydride for 15 
rain, and then blocked and incubated with primary and secondary antibod- 
ies as described above. Comparable results were obtained with either fixa- 
tion protocol. The primary antibodies were YL 1/2, a rat mAb specific for 
tyrosinated ct-tubulin (Kilmartin et al.,  1982; Wheland et al.,  1983), pur- 
chased from Accurate Chemical &  Scientific Corp. (Westbury,  NY), and 
used at 1:100 dilution, and 6-11B-l, a mouse mAb specific for acetylated 
cc-tubulin (Piperno and Fuller, 1985), generously provided by Dr. G. Piperno 
of the Rockefeller University, and used as the undiluted culture supernatant. 
In some experiments, a  mouse general ¢-tubolin mAb (purchased from 
Amersham Corp., Arlington Heights,  IL) was substituted for the 6-1113-1. 
The second antibodies were a fluorescein-conjugated  goat anti-rat adsorbed 
against mouse Ig,  and a Texas red-conjugated goat anti-mouse adsorbed 
against rat Ig, both purchased from Accurate Chemical & Scientific Corp. 
and used at 1:100 dilution. 
Immunoelectron Microscopy 
For immunoclectron microscopic analyses of axonal MTs, explant cultures 
were rinsed briefly in PHEM, extracted for 10 rain with 1% Triton X-100 
in PHEM also containing 10 ttM taxol and 0.2 M NaCI,  and then fixed by 
the addition of an equal volume of PHEM containing 1% glutaraldehyde 
(Folysciences  Inc., Warrington, PA) directly to the extraction buffer. After 
10 min of fixation,  the cultures were rinsed in PHEM, then treated with 2 
mg/mi sodium borohydride in PHEM for 15 min. Subsequent steps in our 
protocol were adapted directly from the standard protocol described by 
Geuens et al. (1986).  After sodium borohydride treatment, cultures were 
rinsed briefly in TBSI  (10 mM "Iris,  140 mM NaCI, pH 7.6), incubated 
with a blocking solution containing 5% normal goat serum in TBSI, in- 
cubated overnight at 4"C with primary antibody (either YL  1/2 used at 
1:200, or a mouse/3-tubulin mAb purchased from Amersham Corp., and 
used at 1:50) diluted in TBSI containing 1% normal goat serum, rinsed ex- 
tensively in TBS2 (20 mM Tris,  140 mid NaCI, pH 8.2) containing 0.1% 
BSA, incubated for 3 h at 35"C with an appropriate second antibody con- 
jugated to 5-nm gold particles (purchased from Janssen Life Sciences,  Pis- 
cataway, NJ) diluted in TBS2 containing 0.1% BSA, and rinsed extensively 
in TBS2. The cultures were then fixed for 10 rain with 1% glutaraldehyde 
in 0.1 M ¢acodylate  also containing 2 mg/ml tannic acid, rinsed in 0.1 M 
cacodylate,  and postfixed  in 2%  OsO4 for  10 rain.  Subsequent steps  in 
electron microscopy  were as previously described (Baas and Heidemann, 
1986).  In some experiments, the epen block was stained for 1 h at 60°C 
with 1% toluidine blue in 1% borax, buffed with lens tissue, and then cow 
ered with a thin layer of immersion oil. This procedure, modified from Bart- 
lett and Banker (1984),  enhanced the resolution of the axon as viewed by 
phase-contrast microscopy,  and hence permitted us to readily  identify the 
most distal regions of the extracted axons. 
Results 
Axons Contain Both Stable and Labile Microtubules 
We previously reported that cultured sympathetic  neurons 
contain two classes  of MTs,  termed  stable and labile, that 
differ in their relative stability to MT depolymerizing drugs 
(Black et al.,  1989).  For the present studies, we wished to 
determine whether or not both classes  of MTs are present 
specifically in the axons of these neurons. To address this is- 
sue, we used morphological means to quantify the MT mass 
in axons as a  function of time in 2/~g/ml  nocodazole (see 
Materials and Methods). Fig. 2 shows the data derived from 
two separate studies. Fig. 2 (a-c) are representative electron 
micrographs of axons treated for 0, 15, and 120 min, showing 
a clear decrease in MT mass with increasing time in drug. 
Somewhat to our surprise, it appeared that a relatively sub- 
stantial portion of the MT mass depolymerized after even 
fairly short treatments with drug. Quantitative analyses re- 
veal that the decrease in MT mass is biphasic (Fig. 2 d), with 
"o48%  of the  MT  mass  depolymerizing  with  a  hr2  of ,,o5 
min,  and the remaining polymer depolymerizing with a  tla 
of ,~ 240 min. These results clearly indicate that axons con- 
tain both stable and labile MTs. 
Stable and Labile Microtubules in the Axon Differ in 
Their ~-Tubulin Composition 
We propose that stable and labile MTs in the axon exist as 
distinct domains on individual MTs rather  than as separate 
Baas and Black Stable and Labile Domains on Axonal Microtubules  497 Figure 2.  Effects of nocodazole on axonal  MTs. a-c show examples  of electron micrographs of axons treated with 2/~g/ml nocodazole 
for 0, 15, and 120 rain,  respectively.  Arrow (c) points to a MT left after drug treatment,  d shows quantitative  data on the effects of drug 
treatment  on axonal MTs. The MT mass contained in drug-treated axons was quantified  morphometrically as described in Materials  and 
Methods, and expressed  as a percentage of that in control axons.  The open and closed circles represent  the data from two separate  sets 
of experiments.  Nocodazole induced a biphasic  decay in the MT mass,  with  '~48% depolymerizing with a t~a of roughly 5 min, and 
,~52% depolymerizing with  a tit2 of roughly 240 min. Bar, 0.2/zm. 
populations of MTs. To test this hypothesis, we must be able 
to simultaneously visualize and distinguish stable and labile 
MTs, and thereby determine  their spatial relationship  rela- 
tive to one another. In this section, we demonstrate that sta- 
ble and labile MTs can be distinguished from one another. 
Then,  in the following section,  we use this  information to 
show that stable and labile MTs exist as distinct domains on 
individual  MTs. 
Stable and labile MTs have been identified in many non- 
neuronal ceils on the basis of differences in their sensitivity 
to MTs depolymerizing drugs. These stable and labile MTs 
are also distinguishable on the basis of their u-tubulin com- 
position;  labile  MTs  are  rich  in  tyrosinated  t~-tubulin, 
whereas stable MTs are rich in ot-tubulin that has been post- 
translationally  detyrosinated and/or acetylated (Gunderson 
and  Bulinski,  1986;  Piperno  et  al.,  1987;  Schulze et  al., 
1987; Kreis,  1987; Webster et al.,  1987; Wheland and Web- 
er,  1987; Gunderson et al.,  1987; Bulinski et al.,  1988). If 
the same situation applies to the axon, then treatment of neu- 
rons with 2/~g/ml nocodazole for a time sufficient to com- 
pletely depolymerize the labile MTs, while only minimally 
affecting the stable MTs, should substantially reduce or com- 
pletely eliminate tyrosinated MTs from the axon while hav- 
ing little or no effect on detyrosinated and acetylated MTs. 
To  test  this  prediction,  control  and  drug-treated  neurons 
were  extracted  to  remove  unassembled  tubulin,  and  then 
double-stained  for immunofluorescence analyses of tyrosi- 
nated and acetylated MTs (see Materials  and Methods). 
Fig. 3 shows the results from these analyses. Each micro- 
graph in the figure shows one or two cell bodies, each having 
Figure 3. Double-label  immunofluorescence analyses using the 6-1113-1 mAb to localize MTs rich in acetylated  o~-tubulin (acetylated  MTs), 
and the YL 1/2 mAb to localize MTs rich in tyrosinated c~-tubulin (tyrosinated  MTs) in neurons that had been treated  for 0, 30, 60, or 
120 min with 2 ~,g/ml nocodazole (see Materials  and Methods).  Each micrograph shows one or two cell bodies, each having one or two 
dendrites  that appear as relatively  short processes that are broad at the base and taper with distance from the cell body. The remaining 
processes are axons. In  control cultures, the staining patterns for tyrosinated and acetylated M'I~ are very similar, although lighter exposures 
reveal subtle differences in the staining patterns i  n the cell body (these will be discussed in a subsequent publication).  Nocodazole treatment 
had minimal effect on the staining pattern for acetylated MTs throughout the neuron. Drug treatment also had minimal effect on the staining 
for tyrosinated MTS in cell bodies and dendrites.  However, tyrosinated MTs in the axon were very labile to drug treatment,  as shown by 
the near absence of staining  for tyrosinated MTs after as little  as 30 min in the drug. Bar, 40 #m. 
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that are broad at the base and taper with distance from the 
cell body. Processes with this appearance were confirmed to 
be dendrites by their staining for MAP-2, a somatodendritic- 
specific marker (data not shown; see also Peng et al., 1986). 
The remaining processes are axons, which typically run to- 
gether in bundles containing varying numbers of axons. Be- 
cause each neuron typically produces only a  single axon 
(Bruckenstein and Higgins, 1988), the vast majority of axons 
appearing in the fields shown in these micrographs originate 
from cell bodies located outside of the field. In control cul- 
tures, both tyrosinated and acetylated MTs are clearly pres- 
ent throughout the cell bodies, dendrites, and axons (Fig. 3, 
a and b). Treatment with 2 #g/ml nocodazole for 30, 60, or 
120 min had no detectable effect on the staining pattern for 
acetylated ct-tubulin (compare Fig. 3 a to c, e, and g). Simi- 
lar results were obtained after an overnight (,M5-h) treatment 
with 2/xg/ml nocodazole, although the intensity of staining 
was reduced considerably compared to controls or to cul- 
tures that had undergone short-term nocodazole treatment 
(data not shown). Likewise, the staining pattern obtained 
using a mAb against total ot-tubulin was not detectably affected 
by nocodazole treatment, although the overall staining inten- 
sity was noticeably reduced at all times (30 min to overnight) 
examined (data not shown). 
The staining pattern for tyrosinated MTs was dramatically 
affected by drug treatment, but in an unexpected manner. 
Treatment with 2 t~g/ml nocodazole for times ranging from 
30 min to 15 h had minimal effect on the staining of the cell 
bodies and dendrites (Fig. 3 and data not shown), and immu- 
noelectron microscopic studies confirmed that the staining 
remaining in the somatodendritic compartment after 2 h of 
drug treatment was in the form of MTs (data not shown). In 
contrast, tyrosinated MTs in the axon were very drug-labile, 
largely disappearing within as little as 30 min of drug treat- 
ment (Fig. 3, compare b with panels d, f, and h). Similar 
results  were  also  obtained with  neurons treated  with  10 
/~g/ml nocodazole. These results demonstrate that cell bod- 
ies and dendrites contain stable MTs, and that these MTs are 
rich in tyrosinated as well as acetylated ot-tubulin.  In con- 
trast, in axons, labile MTs are rich in tyrosinated c~-tubulin, 
whereas stable MTs contain little or no tyrosinated ot-tubu- 
lin, but instead are rich in acetylated c~-tubulin. Furthermore, 
because acetylated ot-tubulin in these neurons is also detyro- 
sinated (Baas and Black, 1989),  stable MTs in the axon are 
also rich in detyrosinated ct-tubulin. 
The above results suggest a close correspondence between 
the relative stability of axonal MTs and their tyrosination 
state. This was confirmed quantitatively by immunoelectron 
microscopic analyses of the distribution of tyrosinated o~-tu- 
bulin among axonal MTs. In these studies, control and drug- 
treated neurons were stained with the YL 1/2 mAb, which 
is specific for tyrosinated ct-tubulin, and an appropriate sec- 
ond antibody conjugated to 5-rim gold particles (see Mater- 
ials and Methods). Roughly half of the MT profiles were la- 
beled all along their length with gold particles, indicating 
that these profiles were rich in tyrosinated tx-tubulin, while 
roughly the other half were completely unlabeled, indicating 
that these profiles were deficient in tyrosinated ,v-tubulin, and 
hence rich in detyrosinated o~-tubulin (Fig. 4, b-e).  Typi- 
cally tyrosinated MT profiles were densely and uniformly 
decorated with gold particles (see Fig. 4 b), but a fraction 
of the MT profiles were noticeably less dense in their label- 
ing (see Fig. 4 c). The significance of this difference in the 
density of labeling is unknown. The presence of labeled and 
unlabeled profiles in our preparations cannot be attributed to 
differences in the ability of the 5-nm gold particles to pene- 
trate different regions of  the axonal mat for two reasons. First, 
densely labeled and completely unlabeled MT profiles were 
frequently observed side-by-side. Second, axons immunola- 
beled with a mAb to/~-tubulin known to label axonal MTs 
from other systems all along their length (Joshi and Cleve- 
land, 1989) labeled all MT profiles in our preparation; most 
(i>90%) profiles labeled for/3-tubulin densely and uniformly, 
with only a very small number of profiles (x<10%) showing 
short regions of somewhat sparser labeling (Fig. 4 a). Col- 
lectively, these observations indicate that the results obtained 
with the YL 1/2 mAb are not artifacts of penetration prob- 
lems, but instead accurately reflect the existence of composi- 
tionally distinct MTs in the axon. 
Table I  shows the results of quantitative analyses of the 
effects of nocodazole treatment on relative proportions of 
tyrosinated and detyrosinated MTs in the axon. In control 
cultures, 48 % of the MT mass was tyrosinated, while the re- 
maining 52%  was detyrosinated. After 15 min in nocoda- 
zole, roughly the amount of  time needed to depolymerize the 
labile MTs without affecting the stable MTs (see Fig. 2 d), 
only 7%  of the MT mass was  tyrosinated (Fig.  5),  thus 
decreasing the tyrosinated MT mass in the axon by ~85 %. 
After 30 min, 4% of the MT mass was tyrosinated, and after 
60 min, no tyrosinated MTs remained. These data indicate 
that the tyrosinated MTs in the axon represent essentially the 
same  subset  of axonal  MTs  that are  labile,  and that the 
detyrosinated MTs in the axon represent the same subset of 
axonal MTs that are stable. Thus, tyrosinated ot-tubulin can 
be used as a reliable and highly specific marker that distin- 
guishes the labile MTs from the stable MTs in the axon. 
We note that the tyrosinated MT profiles remaining after 
drug treatment were entirely similar in appearance to the 
tyrosinated MT profiles in control cultures, and were not 
preferentially of either the more or less densely labeled type. 
The low levels of tyrosinated MTs in the axon remaining af- 
ter drug treatment may reflect recently stabilized MTs that 
have not yet undergone a substantial degree of detyrosina- 
tion. This interpretation is consistent with the temporal de- 
lay known to occur between MT stabilization and detyrosi- 
nation (Khawaja et al.,  1988). 
Stable and Labile Microtubules in the Axon Represent 
Distinct Domains on Individual Microtubules 
If stable and labile MTs in the axon exist as distinct domains 
on individual MTs,  then it should be possible to identify 
composite MTs in the axon that label for tyrosinated a-tubu- 
lin at one end but not at the other. Indeed, several examples 
of MT profiles labeled in this manner were observed (Fig. 
6). In all these cases, there was an abrupt transition between 
the labeled and unlabeled regions. The existence of these 
composite profiles indicates that at least some MTs in the 
axon consist of both a stable and a labile domain. We esti- 
mated the frequency of this type of MT taking into account 
the following considerations. The average length of an MT 
profile in our electron micrographs is ,~1/~m, while the aver- 
age length of an entire MT in the axons of cultured neurons 
The Journal of Cell Biology, Volume 111,  1990  500 Figure 4. Electron micrographs of axo~al MTs immunolabelexi  with a mAb against either total B-tubulin (a) or with the YL 1/2 mAb against 
tyrosinated c~-tubulin (b,eL and appropriate second antibodies conjugated to 5-nm gold particles. (a) In samples stained with the B-mbulin 
antibody, all MTs were labeled, and most were heavily labeled all along their length. On rare occasions, short segments of MTs were ob- 
served that were labeled somewhat more sparsely than the more typical heavily labeled profiles (arrow). (b-e) In samples stained with 
the YL 1/2 mAb, the vast majority of MT profiles either were labeled more or less uniformly all along their lengths, or were completely 
unlabeled. Some of the labeled profiles were less densely labeled than others; arrow (d) shows a less densely labeled profile situated above 
a more densely labeled profile. In addition, some MT profiles showed regions of dense labe$ing in direct continuity with unlabeled regions 
(e, straight arrow), e also shows an example of overlapping MTs decorated with gold particles in which it was not possible to determine 
which MT was specifically associated with the gold particles (curved arrow). Bar,  0.2 ltm. 
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Labels with YL 1/2 in Immunoelectron 
Microscopic Analyses 
Time in drug  Labeled  Unlabeled  Percent 
(rain)  (,urn)  ~m  )  labeled 
0  482  522  48 
15  71  933  7 
30  41  961  4 
60  0  1,000  0 
Axons treated for 0-60 min with 2/~g/ml nocodazole were intmunolabeled  for 
tyrosinated ,',-tubulin with the mAb YL 1/2 (see Materials and Methods). For 
each time point, a total of ,'~1,000 t~m of MT profiles on randomly selected 
micrographs were scored as either labeled or unlabeled (see Results). A small 
number of profiles on some micrographs  were not scored  because of ambigui- 
ties resulting from closely spaced MT, one or more of which may have been 
labeled. The total lengths of the unlabeled and labeled profiles for each time 
point were then summed separately  and recorded in the table. 
is ~100 ~m (Bray and Bunge,  1981).  Thus, if all MTs in the 
axon consist of one stable domain and one labile domain, we 
would expect 1% of the profiles to show the transition region 
between  these  domains.  In  our  studies,  21  of 5,000  MT 
profiles,  or  ,x,0.4%,  showed both domains,  suggesting  that 
•40%  of the MTs in the axon consist of both domains.  The 
true proportion is probably higher in that we used very strin- 
gent criteria  in  scoring  MT profiles consisting  of both do- 
mains,  eliminating  several  possible  candidates  because  of 
neighboring MTs to which the gold particles might have al- 
ternatively been associated (Fig. 4 e). Collectively, these ob- 
servations  indicate  that a  sizable proportion of MTs  in the 
axon consist of a relatively stable domain in direct continuity 
with a  more labile domain. 
Which end of the composite MT is stable and which end 
is labile? Explant cultures were especially useful in address- 
ing this question because all of the axons from an explant cul- 
ture grow in the same direction relative to the cell body mass 
(Fig.  1).  Thus,  all of the MTs in a  region of axons selected 
for thin-sectioning  have the same polarity orientation,  plus 
ends distal to the cell body mass, permitting ready determi- 
nation  of the plus  and  minus  ends  of each  MT  profile ob- 
served  in  our  electron  micrographs.  In  all  21  of the  MT 
profiles  we  observed  showing  both  stable  and  labile  do- 
mains, the labile domain was always situated at the plus end 
of the stable domain  (Fig.  6). 
Distribution of  Stable and Labile Microtubules 
in the Axon 
The immunofluorescence experiments shown in Fig.  3 indi- 
cate that stable and labile MTs are distributed throughout all 
regions of the axon discernable in moderate density cultures. 
However,  the high degree of axonal bundling  in these cul- 
tures precluded detailed analyses of the labeling patterns all 
along the length of the axon.  Therefore, in a  separate set of 
experiments,  we analyzed the distribution  of stable and la- 
bile MTs in the axons of lower density cultures. In these cul- 
tures, individual axons were minimally 2-mm in length, and 
stained for tyrosinated MTs all along their length.  However, 
there was a  clear diminution  in the intensity of staining  for 
tyrosina.ted MTs moving from the distal region of the axon 
into its main shaft.  The most distal 25-75  #m of the axon 
stained brightly for tyrosinated MTs (Fig. 7), with the inten- 
sity of staining  gradually  decreasing  over the  next  15-100 
#m, reaching a relatively constant level of staining over the 
remaining portion of the axon (not shown).  The same axons 
stained more or less uniformly for acetylated MTs all along 
their  length,  except  at their  most distal  region  contiguous 
with the growth cone, which stained poorly or not at all (Fig. 
7). Thus, the most distal region of the axon stained for tyrosi- 
nated MTs but not for acetylated MTs. The length of this distal 
region varied among different axons, ranging from ~10 #m 
(Fig. 7, c and e) to ,ol-2 #m (Fig. 7, d and  f). These observa- 
tions were confirmed by immunoelectron microscopic analy- 
•gure  5. Electron micrographs 
of MT profiles in  axons that 
were treated for 15 min with 2 
#g/ml  nocodazole,  and  im- 
munolabeled to reveal tyrosi- 
nated c~-tubulin, a  is a typical 
region,  showing  many  unla- 
beled but no labeled MT pro- 
files,  b is a much less typical 
region,  showing  many  unla- 
beled MT profiles and one la- 
beled profile. Bar, 0.2 #m. 
The Journal of Cell Biology, Volume 111, 1990  502 Figure 6. Higher magnification electron micrographs revealing composite MT profiles that were labeled at one end for tyrosinated a-tubulin 
but not at the other end. In the fields shown, the axons were growing from the left to the right.  Axonal MTs are oriented with their plus 
ends pointing away from the cell body and toward the axon tip (Heidemann et al., 1981). Relative to the axonal fields illustrated in this 
figure, the cell bodies are situated toward the leR and the axon tips are situated toward the right (the cell bodies and axon tips are located 
outside the fields shown). Thus, the MTs in each field have their minus ends toward the leR anti their plus ends toward the right.  Note 
that for all composite MT profiles, the regions labeled for tyrosinated ct-tubulin are toward the fight of the panels. Hence, the tyrosimted 
domains of composite MTs are situated at the plus ends of the detyrosinated domains. In addition, in all cases there is an abrupt transition 
between the labeled and unlabeled regions (arrows). a is a higher magnification photograph of the MT profiles shown in e of Fig. 4. Bar, 
0.1 #m. 
ses; in three different axons examined, all of the MT profiles 
in the most distal  1-2 #In were labeled densely for tyrosi- 
hated ot-tubulin,  while none of the  MT profiles were unla- 
beled (Fig.  8).  Since tyrosinated MTs correspond to labile 
MTs in the axon, these results indicate that the distal region 
of the axon contains only labile MTs. Indeed, in five different 
axons treated  with  2  #g/ml nocodazole for  15  rain,  time 
sufficient to completely depolymerize labile MTs in the axon 
(Fig. 2), the most distal 1-2 #m contained no MTs, differing 
from control axons that contained several MTs in their distal 
regions (Fig. 9). This contrasts with the situation in the main 
shaft of the axon, which contains roughly equal amounts of 
stable and labile> MTs (see above, Fig. 4, b-e).  Thus, both 
stable and labile MTs are present throughout the length of 
the ax0n, with the exception of its most distal region contigu- 
ous with the growth cone, which contains only labile MTs. 
Discussion 
Our studies reveal a strong correlation between the stability 
properties of axonal MTs and their tyrosination state. Roughly 
48%  of the MT mass in the axons of cultured  sympathetic 
neurons is labile, depolymerizing with a  tla of ,,o5 rain in 
the presence Of 2  #g/ml nocodazole,  while the  remaining 
52 % of the MT mass is stable, depolymerizing with a t~ of 
,,o 240 rain under these conditions (Fig. 2). Immunofluores- 
cence analyses indicate that labile MTs in the axon are rich 
in tyrosinated a-tubulin,  whereas stable MTs contain little 
or no tyrosinated o~-tubulin, but instead are rich in acetylated 
and detyrosinated ot-tubulin (Fig.  3). Quantitative analyses 
performed atthe  immunoelectron microscopic level con- 
firmed this result, indicating that ,,o85%  of the tyrosinated 
M~in the axon are depolymerized v~ithin 15 min of nocoda, 
Baas and Black  StaMe and LaBile  Domains on  Axonal  Microtubules  503 Figure 7.  Phase-contrast (a and b) and immunofluorescence (c-f) images of the distal regions of two different axons double stained to 
reveal labile and stable MTs. Labile MTs were visualized with the mAb YL 1/2 against tyrosinated ¢-mbulin (c and d), while stable MTs 
were visualized with the mAb 6-11B-1 against acetylated c~-mbulin (e and f). Labile and stable MTs have similar distributions along the 
length of the axon, except in the most distal region, contiguous with the growth cone, which contains only labile MTs. Arrowheads mark 
sites where growth cones end. Unlabeled structures in b (above left arrowhead, and parallel to the axon in the middle) are collagen fibers. 
Bar, 30 ttm. 
zole treatment, time sufficient to completely depolymerize 
the labile Mrs in the axon while only minimally affecting the 
stable MTs (Fig. 5, Table I). These results demonstrate that 
tyrosinated  cx-mbulin  is  a  reliable  and  highly  specific  marker 
for  labile  MTs in  the axon, and can be used to distinguish 
stable and labile MTs in microscopic analyses of the axon. 
We have taken advantage of  these findings to simultaneously 
visualize and distinguish stable and labile MTs in the axon, 
and hence determine their distribution and spatial relation- 
ship relative to one another. 
The Journal of Cell Biology, Volume I 1  I, 1990  504 Figure 8. Phase-contrast  (a) and immunoelectron (b and c) micrographs of the distal regions of axons immunolabeled to reveal tyrosinated 
tx-tubulin. The phase-contrast  image of the extracted axons was enhanced by staining of the epon block with toluidine blue (see Materials 
and Methods).  In the most distal  1-2/~m of the axon (a, arrows), all of the MTs are densely labeled for tyrosinated ~t-tubulin (b and c). 
Bar, (a) 10/~m;  (b) 0.2 tLm. 
Stable and Labile Microtubules Coexist along the 
Length of the Axon 
Qualitative immunofluorescence analyses localizing tyrosi- 
hated and acetylated MTs in a  variety of neuronal systems 
indicate that the main shaft of the axon contains both stable 
and labile MTs, whereas the most distal region of the axon 
contiguous with the growth cone contains predominantly la- 
bile MTs (Figs. 3 and 7; see also Wheland and Weber, 1987; 
Robson and Burgoyne,  1988;  Lim et al.,  1989).  We have 
confirmed and expanded upon these results quantitatively by 
showing that similar levels of stable and labile MTs are pres- 
ent,  and  situated  side-by-side with one another,  along the 
main shaft of the axon (Figs. 2 and 4, b-e), whereas exclu- 
sively labile MTs are present in the distal region of the axon 
contiguous with the growth cone (Figs. 8 and 9). Collectively, 
these results indicate that both stable and labile MTs coexist 
throughout the axon, except in its most distal region, which 
contains only labile MTs. 
An initially  surprising  aspect of our data concerned the 
relative proportions of stable and labile MTs in the axon. 
Many studies on the properties of MTs in the axon have fo- 
cused on the greater stability of axonal MTs compared to the 
rapidly turning-over MTs characteristic of proliferating cell 
types (Morris and Lasek,  1982;  Black and Greene,  1982; 
Black et al.,  1984,  1989;  Brady et al.,  1984;  White et al., 
Figure 9.  Electron  micrographs  of the 
most distal  1-2 #m of the axon. a is an 
axon from a control culture,  whereas b 
is an axon from a culture treated for 15 
min with  nocodazole  to depolymeriz¢ 
labile  MTs. MTs extend into  the most 
distal  1-2 #m of the control  axon,  but 
are completely absent from the same re- 
gion  of the  nocodazole-treated  axon. 
Note  that  as  expected  (Joshi  et  al., 
1986),  the  drug-treated  axon  contains 
many more membranous  profiles  than 
the control axon. Bar, 0.2 #m. 
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els of stable MTs in the axons of cultured sympathetic neu- 
rons,  our  studies  also  indicate  that  a  sizable  proportion 
(~,48%) of the MT mass in these axons is labile, completely 
depolymerizing within the first 15 min in nocodazole (Fig. 
2). Because a high sensitivity to MT depolymerizing drugs 
generally indicates a rapid rate of subunit exchange, these 
results suggest that roughly half of the MT mass in the axon 
is very dynamic. Other studies also suggest substantial MT 
dynamics in axons. For example, 50% or more of the MT 
mass in diverse systems such as the squid giant axon (Morris 
and Lasek, 1984), mature mammalian axons (Heidemann et 
al.,  1984), and the axons of cultured chick sensory neurons 
(Baas  and  Heidemann,  1986)  rapidly  disassemble  in  re- 
sponse to MT depolymerizing conditions. Also, haptenized- 
tubulin microinjected into PC12 cells and cultured neurons 
rapidly incorporates into the MTs of their axons (Okabe and 
Hirokawa,  1988,  1990), suggesting relatively rapid subunit 
exchange between axonal MTs and the soluble tubulin pool. 
These findings suggest that MT dynamics comparable in de- 
gree to those observed in the axons of cultured sympathetic 
neurons may be a general feature of axons. 
It has been proposed that local assembly of MTs in the 
axon and particularly at the axon tip contributes to the net 
addition of MTs to the axon during axon growth (Bamburg 
et al.,  1986;  Robson and Burgoyne,  1988;  Mitchison and 
Kirschner, 1988). This proposal derives from evidence sug- 
gesting that MTs in the distal region of the axon undergo 
rapid assembly/disassembly dynamics. As indicated above, 
our studies confirm such dynamics at the axon tip, and also 
demonstrate  substantial  assembly/disassembly  dynamics 
throughout the length of  the axon. Unfortunately, the demon- 
stration of local MT dynamics in the axon does not directly 
address the contribution of local MT assembly to the net ad- 
dition of MTs to the growing axon. While local assembly 
may increase the MT mass of the axon, it is also possible the 
assembly  events  are  perfectly  balanced  by  disassembly 
events within the MT array of the axon. New information 
will be required to resolve this issue. 
A somewhat unexpected finding from our studies was that 
while tyrosinated ot-tubulin is a reliable marker for labile 
MTs in the axon, it is not a reliable marker for labile MTs 
in the somatodendritic compartment of the neuron. MTs in 
cell bodies and dendrites contain high levels of tyrosinated 
ot-tubulin,  but as  shown in Fig.  3,  some portion of these 
tyrosinated MTs are  stable to  drug  treatments  that com- 
pletely depolymerize  tyrosinated MTs in the axon. Thus, sta- 
ble MTs are present in the somatodendritic compartment of 
the neuron as well as in the axon, but stable MTs in cell bod- 
ies and dendrites, as opposed to those in the axon, contain 
tyrosinated u-tubulin. Furthermore, based on the relative in- 
tensity of MT staining in control and drug-treated neurons, 
these stable but tyrosinated MTs represent a substantial frac- 
tion of the total MT mass present in cell bodies and den- 
drites. 
Stable and Labile Microtubules Represent Distinct 
Domains on Individual Microtubules in the Axon 
In addition to MT profiles that were either labeled for tyrosi- 
hated ot-tubulin all along their length or were completely un- 
labeled,  immunoelectron microscopic analyses revealed a 
third type of MT profile that was densely labeled for tyrosi- 
nated ot-tubulin at one end, but was completely unlabeled at 
the other end. In all of these cases, the tyrosinated domain 
of these profiles was situated at the plus end of the detyrosi- 
nated domain, and there was an abrupt transition between 
the two domains (Fig. 6). The existence of this third type of 
profile indicates that at least some MTs in the axon are com- 
posite, consisting of a dctyrosinated domain in direct con- 
tinuity with a tyrosinated domain. Additional considerations 
provide information on the number of distinct tyrosinated 
and detyrosinated domains comprising these composite MTs. 
First, the fact that in any given section most MT profiles, 
regardless of their length, were either completely and uni- 
formly labeled for tyrosinated o~-tubulin or were completely 
unlabeled suggests that axonal MTs have relatively infrequent 
transitions from one type of domain to the other. Indeed, 
even the longest MT profiles captured in our sections (•4 
#m) contained no more than two domains. Second, the find- 
ing that tyrosinated MTs in the axon are depolymerized by 
*85% within the first 15 min in nocodazole, and are com- 
pletely depolymerized by 1 h (Fig. 5; Table I), indicates that 
only a very small portion of the tyrosinated MTs in the axon 
could be buried within the more stable detyrosinated do- 
mains. Finally, if a tyrosinated domain were flanked by two 
detyrosinated domains, or vice versa, we would expect to 
capture detyrosinated domains at the plus ends of tyrosinated 
domains equally as often as the reverse orientation. How- 
ever, in all 21 composite profiles we observed, the tyrosi- 
nated domain was  always  situated  at the plus  end of the 
detyrosinated domain. Collectively, these observations sug- 
gest that composite MTs in the axon consist of one tyrosi- 
nated domain situated toward the plus end of the MT, and 
one detyrosinated domain situated toward the minus end of 
the MT. Furthermore, because tyrosinated and detyrosinated 
MTs in the axon correspond to labile and stable MTs respec- 
tively, we conclude that composite MTs consist of a single 
labile domain in direct continuity with a  single stable do- 
main, with the labile domain always situated at the plus end 
of the stable domain. 
We tentatively estimate that 40% of the MTs in the axon 
are composite. This estimate is based on the observed fre- 
quency of MT profiles showing a transition region between 
the labile and stable domains, on the assumption that MTs 
in the axons studied average ,x,100 #m in length, and on the 
probability of capturing the transition region between the la- 
bile and stable domains of individual MTs in our sections 
(see Results). Because very strict criteria were used in scor- 
ing MT profiles consisting of both domains, the actual pro- 
portion of composite MTs in the axon may be much higher 
(see Results). Thus, the results of  our studies clearly indicate 
that a sizable proportion of MTs in the axon are composite, 
consisting of one stable domain in direct continuity with one 
labile domain. 
Both the extreme drug sensitivity of the labile domains and 
the abrupt transition in tyrosination state between the stable 
and labile domains on composite MTs suggests that the labile 
domains turnover very rapidly, more rapidly than the rates 
at which they can be detyrosinated. Conversely, the relative 
insensitivity of the stable domains to drug-induced depoly- 
merization and their high levels of detyrosinated and acet- 
ylated ot-tubulin indicate that these MTs turnover quite slowly 
relative to the labile domains. The direct continuity of the 
rapidly turning over labile domains with the slowly turning 
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Figure 10. Schematic depicting the spatial organization of labile and stable MTs in the axon. The plus ends of the MTs are directed away 
from the cell body, while the minus ends of the MTs are directed toward the cell body. A sizable proportion of the MTs in the axon consist 
of two domains, a relatively stable domain at the minus end, and a more labile domain at the plus end. In addition, the axon may contain 
some MTs that are entirely stable (indicated with question marks). These MTs may be entirely stable because they are capped against 
assembly at both ends, or because their labile domains have recently undergone catastrophic disassembly (see text). The existence of  entirely 
labile MTs in the axon is doubtful in that new MT assembly in the axon is apparently restricted to elongation from preexisting MTs (see 
text). Both labile and stable MT domains are present all along the length of  the axon, except in the most distal region of the axon contiguous 
with the growth cone, into which extend only the labile domains of MTs originating more proximally in the axon. The schematic also 
depicts MTs in the cell body as consisting of both domains. At present, this is hypothetical; we have identified stable and labile MTs in 
the cell body, but have not explored their spatial relationship relative to one another. 
over stable domains thus indicates that the labile MTs assem- 
ble directly from the stable MTs. It therefore follows that the 
plus ends of stable MTs are assembly competent, and nucle- 
ate MT assembly in the axon. Recent studies on MT dynamics 
in isolated segments of the axon (Baas and Heidemann, 1986) 
further suggest that stable MTs represent the only long-lived 
templates for MT assembly in the axon. In these studies, iso- 
lated segments of the axon were treated with varying doses 
of nocodazole, rinsed free of the drug, and then evaluated for 
MT reassembly by electron microscopy. MT reassembly oc- 
curred rapidly during recovery from drug treatments that 
depleted labile but not stable MTs, but did not occur during 
recovery from drug treatments that depleted the stable as 
well as the labile MTs. These results indicate that MT assem- 
bly in the axon occurs by elongation from preexisting MTs 
rather than by self-association of tubulin subunits into new 
MTs or by elongation from non-MT nucleating structures. 
Thus, stable MTs are not only assembly competent, but also 
apparently  represent the  preferred and  perhaps  exclusive 
templates for local MT dynamics in the axon. 
The mechanisms that underlie the rapid turnover of labile 
MTs in the axon are a matter of speculation at present. In 
many cell types, the rapid turnover of MTs can be explained 
by the dynamic instability model (for review, see Kirschner 
and Mitchison, 1986). Assuming that dynamic instability ac- 
counts for aspects of MT turnover in the axon (Mitchison and 
Kirschner, 1988), it seems reasonable to suggest that the la- 
bile domains of axonal MTs may be dynamically unstable, 
undergoing rapid phases of elongation from the plus ends of 
stable MTs, followed by catastrophic disassembly of the la- 
bile MTs either partially or completely back to the plus ends 
of the stable domains. In this view, the stable MTs not only 
serve as templates for local MT dynamics in the axon, but 
also rescue catastrophic disassembly of the labile domains 
and thereby ensure the continued existence of the MTs. Be- 
cause axons apparently lack the ability to generate MTs de 
novo (Baas and Heidemann, 1986), this rescue function may 
be particularly important for maintaining the MT array of 
the axon. 
Stable Microtubules Organize Microtubule Assembly 
in the Axon 
Fig.  10 schematically summarizes the contribution of the 
present study to current understanding of the organization of 
MTs in the axon. Previous studies have shown that axonal 
MTs do not radiate from a single, centrally situated nucleat- 
ing structure (Lyser, 1968; Sharp et al., 1982; Stevens et al., 
1988; Okabe and Hirokawa, 1988), but rather start and stop 
at multiple sites along the length of the axon (Chalfie and 
Thompson, 1979; Bray and Bunge,  1981; Tsukita and Ishi- 
kawa,  1981). Our studies suggest that most MTs in the axon 
are composite, consisting of a labile domain in direct con- 
tinuity with the plus end of a stable domain. Entirely stable 
MTs are depicted with question marks; while we have no di- 
rect evidence that such MTs exist, they may in principle be 
generated from composite MTs after complete catastrophic 
disassembly of their labile domains. No entirely labile MTs 
are depicted because labile MTs are proposed to elongate 
specifically from the plus ends of stable MTs (see above). 
Furthermore, any spontaneously formed labile MTs would 
be at a kinetic disadvantage compared to composite MTs, 
and so would be expected to depolymerize in favor of elonga- 
tion from composite MTs (Kirschner and Mitchison, 1986). 
The plus ends of stable MTs are distributed all along the 
length of the axon, indicating that stable templates for local 
MT dynamics exist throughout the axon. Labile MTs that 
grow from these templates will have the same polarity orien- 
tation as the templates themselves, which is plus end distal 
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cause assembly occurs preferentially  from the plus ends of 
the stable MTs,  MT assembly in the axon will occur in a 
direction away from the call body toward the axon tip. Thus, 
stable  MTs  organize  the  assembly  of MTs  in a  common 
direction in the axon, and with a common polarity orienta- 
tion.  These observations indicate-that  stable MTs  spatially 
organize MT assembly in the axon in much the same way that 
traditional MT nucleating structures such as the centrosome 
organize MT assembly in other cell types. However, unlike 
the centrosome, which organizes MT assembly from a dis- 
crete, often centralized location in the cell, stable MTs in the 
axon organize assembly from multiple sites that are widely 
distributed  along the length of the axon. 
The preceding  discussion  has  emphasized  the potential 
role of stable MTs as nucleating structures  for local MT as- 
sembly/disassembly dynamics in the axon. In particular, we 
have suggested that stable MTs may be the only long-lived 
templates for MT assembly in the axon, and, as such, they 
will help ensure the continued existence of the axonal MT 
array. An issue not addressed by the present studies but of 
obvious relevance concerns the generation of the stable MT 
array of the axon. This issue encompasses many questions, 
including how and where stable MTs are generated, and how 
stable MTs obtain their uniformly plus-end-distal polarity 
orientation. Studies are in progress to begin answering these 
questions. 
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